Patents by Inventor Solomon Ugashe

Solomon Ugashe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ARYL SULFONAMIDES
    Publication number: 20110021523
    Abstract: Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists.
    Type: Application
    Filed: October 1, 2010
    Publication date: January 27, 2011
    Applicant: CHEMOCENTRYX, INC.
    Inventors: Solomon Ugashe, Zheng Wei, J.J. Wright, Andrew Pennell
  • ARYL SULFONAMIDES
    Publication number: 20090270616
    Abstract: Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists.
    Type: Application
    Filed: July 7, 2009
    Publication date: October 29, 2009
    Applicant: CHEMOCENTRYX, INC
    Inventors: Solomon Ugashe, Zheng Wei, J.J. Wright, Andrew Pennell
  • Aryl sulfonamides
    Patent number: 7582661
    Abstract: Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: September 1, 2009
    Assignee: ChemoCentryx, Inc.
    Inventors: Solomon Ugashe, Zheng Wei, John J. Wright, Andrew Pennell
  • Aryl Sulfonamides
    Publication number: 20090118307
    Abstract: Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists.
    Type: Application
    Filed: October 15, 2008
    Publication date: May 7, 2009
    Applicant: CHEMOCENTRYX, INC.
    Inventors: Solomon Ugashe, Zheng Wei, J.J. Wright, Andrew Pennell
  • ARYL SULFONAMIDES
    Publication number: 20080293717
    Abstract: Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists.
    Type: Application
    Filed: July 2, 2008
    Publication date: November 27, 2008
    Applicant: CHEMOCENTRYX, INC.
    Inventors: SOLOMON UGASHE, Zheng Wei, J.J. Wright, Andrew Pennell
  • Aryl sulfonamides
    Publication number: 20040171654
    Abstract: Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists.
    Type: Application
    Filed: November 17, 2003
    Publication date: September 2, 2004
    Inventors: Solomon Ugashe, Zheng Wei, J. J. Wright, Andrew Pennell
  • Bis-aryl sulfonamides
    Publication number: 20040167113
    Abstract: Compounds are provided that act as potent antagonists of chemokine receptors. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of chemokine receptor-mediated diseases, and as controls in assays for the identification of chemokine antagonists.
    Type: Application
    Filed: November 18, 2003
    Publication date: August 26, 2004
    Inventors: Solomon Ugashe, Zheng Wei, J.J. Wright, Andrew Pennell, Brett Premack, Thomas Schall